These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 28573734)

  • 1. IL-17A blockade or deficiency does not affect progressive renal fibrosis following renal ischaemia reperfusion injury in mice.
    Thorenz A; Völker N; Bräsen JH; Chen R; Jang MS; Rong S; Haller H; Kirsch T; Vieten G; Klemann C; Gueler F
    J Pharm Pharmacol; 2017 Sep; 69(9):1125-1135. PubMed ID: 28573734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of IL-18 reduces renal fibrosis after ischemia-reperfusion.
    Liang H; Xu F; Zhang T; Huang J; Guan Q; Wang H; Huang Q
    Biomed Pharmacother; 2018 Oct; 106():879-889. PubMed ID: 30119258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detrimental functions of IL-17A in renal ischemia-reperfusion injury in mice.
    Xue L; Xie K; Han X; Yang Z; Qiu J; Zhao Z; Bao T
    J Surg Res; 2011 Nov; 171(1):266-74. PubMed ID: 20400117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal ischemia-reperfusion injury causes hypertension and renal perfusion impairment in the CD1 mice which promotes progressive renal fibrosis.
    Greite R; Thorenz A; Chen R; Jang MS; Rong S; Brownstein MJ; Tewes S; Wang L; Baniassad B; Kirsch T; Bräsen JH; Lichtinghagen R; Meier M; Haller H; Hueper K; Gueler F
    Am J Physiol Renal Physiol; 2018 May; 314(5):F881-F892. PubMed ID: 29357437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Atypical Chemokine Receptor 2 Limits Progressive Fibrosis after Acute Ischemic Kidney Injury.
    Lux M; Blaut A; Eltrich N; Bideak A; Müller MB; Hoppe JM; Gröne HJ; Locati M; Vielhauer V
    Am J Pathol; 2019 Feb; 189(2):231-247. PubMed ID: 30448408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMGB1-TLR4-IL-23-IL-17A axis accelerates renal ischemia-reperfusion injury via the recruitment and migration of neutrophils.
    Zhang J; Li Q; Zou YR; Wu SK; Lu XH; Li GS; Wang J
    Int Immunopharmacol; 2021 May; 94():107433. PubMed ID: 33592404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-17C neutralization protects the kidney against acute injury and chronic injury.
    Zhang F; Yin J; Liu L; Liu S; Zhang G; Kong Y; Wang Y; Wang N; Chen X; Wang F
    EBioMedicine; 2023 Jun; 92():104607. PubMed ID: 37263138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-33 signaling contributes to renal fibrosis following ischemia reperfusion.
    Liang H; Xu F; Wen XJ; Liu HZ; Wang HB; Zhong JY; Yang CX; Zhang B
    Eur J Pharmacol; 2017 Oct; 812():18-27. PubMed ID: 28668506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy.
    Baldeviano GC; Barin JG; Talor MV; Srinivasan S; Bedja D; Zheng D; Gabrielson K; Iwakura Y; Rose NR; Cihakova D
    Circ Res; 2010 May; 106(10):1646-55. PubMed ID: 20378858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-17 mediates neutrophil infiltration and renal fibrosis following recovery from ischemia reperfusion: compensatory role of natural killer cells in athymic rats.
    Mehrotra P; Collett JA; McKinney SD; Stevens J; Ivancic CM; Basile DP
    Am J Physiol Renal Physiol; 2017 Mar; 312(3):F385-F397. PubMed ID: 27852609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of clusterin with renal inflammation and fibrosis after the recovery phase of ischemia-reperfusion injury.
    Guo J; Guan Q; Liu X; Wang H; Gleave ME; Nguan CY; Du C
    BMC Nephrol; 2016 Sep; 17(1):133. PubMed ID: 27649757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D deficiency contributes to vascular damage in sustained ischemic acute kidney injury.
    de Bragança AC; Volpini RA; Mehrotra P; Andrade L; Basile DP
    Physiol Rep; 2016 Jul; 4(13):. PubMed ID: 27369932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous and exogenous pentraxin-3 limits postischemic acute and chronic kidney injury.
    Lech M; Römmele C; Gröbmayr R; Eka Susanti H; Kulkarni OP; Wang S; Gröne HJ; Uhl B; Reichel C; Krombach F; Garlanda C; Mantovani A; Anders HJ
    Kidney Int; 2013 Apr; 83(4):647-61. PubMed ID: 23325083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TSC1 Affects the Process of Renal Ischemia-Reperfusion Injury by Controlling Macrophage Polarization.
    Hu X; Xu Y; Zhang Z; Tang Z; Zhang J; Luo Y; Deng W; Dong Z; Zhao Y; Na N
    Front Immunol; 2021; 12():637335. PubMed ID: 33767704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-17A produced by both γδ T and Th17 cells promotes renal fibrosis via RANTES-mediated leukocyte infiltration after renal obstruction.
    Peng X; Xiao Z; Zhang J; Li Y; Dong Y; Du J
    J Pathol; 2015 Jan; 235(1):79-89. PubMed ID: 25158055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mincle receptor in macrophage and neutrophil contributes to the unresolved inflammation during the transition from acute kidney injury to chronic kidney disease.
    Wang C; Zhang Y; Shen A; Tang T; Li N; Xu C; Liu B; Lv L
    Front Immunol; 2024; 15():1385696. PubMed ID: 38770013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role of interleukin-17A in murine intestinal ischemia-reperfusion injury.
    Lee HT; Kim M; Kim JY; Brown KM; Ham A; D'Agati VD; Mori-Akiyama Y
    Am J Physiol Gastrointest Liver Physiol; 2013 Jan; 304(1):G12-25. PubMed ID: 23125155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced activation of interleukin-10, heme oxygenase-1, and AKT in C5aR2-deficient mice is associated with protection from ischemia reperfusion injury-induced inflammation and fibrosis.
    Thorenz A; Derlin K; Schröder C; Dressler L; Vijayan V; Pradhan P; Immenschuh S; Jörns A; Echtermeyer F; Herzog C; Chen R; Rong S; Bräsen JH; van Kooten C; Kirsch T; Klemann C; Meier M; Klos A; Haller H; Hensen B; Gueler F
    Kidney Int; 2018 Oct; 94(4):741-755. PubMed ID: 29935951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2/PGE2 pathway.
    Bai M; Zhang L; Fu B; Bai J; Zhang Y; Cai G; Bai X; Feng Z; Sun S; Chen X
    Kidney Int; 2018 Apr; 93(4):814-825. PubMed ID: 29132705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Phase Mast Cell Activation Determines the Chronic Outcome of Renal Ischemia-Reperfusion Injury.
    Danelli L; Madjene LC; Madera-Salcedo I; Gautier G; Pacreau E; Ben Mkaddem S; Charles N; Daugas E; Launay P; Blank U
    J Immunol; 2017 Mar; 198(6):2374-2382. PubMed ID: 28167630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.